Study of Oral Atogepant Tablets to Assess Change in Disease Activity in Adult Japanese Participants With Episodic Migraine
Clinical trial NCT05861427 · COMPLETED
Trial details
- NCT number
- NCT05861427
- Sponsor
- AbbVie
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-12
- Primary completion
- 2025-03-01
- Enrollment
- 524
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.